TG Therapeutics Inc (TGTX)
15.42
+1.76
(+12.88%)
USD |
NASDAQ |
May 01, 13:12
TG Therapeutics Shares Outstanding: 154.42M for Feb. 23, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 23, 2024 | 154.42M |
December 31, 2023 | 151.42M |
November 01, 2023 | 151.41M |
September 30, 2023 | 151.45M |
August 02, 2023 | 150.98M |
June 30, 2023 | 150.93M |
May 02, 2023 | 149.40M |
April 17, 2023 | 149.40M |
March 31, 2023 | 149.40M |
February 17, 2023 | 146.36M |
December 31, 2022 | 146.39M |
November 04, 2022 | 145.34M |
September 30, 2022 | 145.36M |
August 02, 2022 | 145.27M |
June 30, 2022 | 145.16M |
May 06, 2022 | 144.44M |
April 20, 2022 | 144.45M |
March 31, 2022 | 144.54M |
February 23, 2022 | 142.82M |
December 31, 2021 | 143.25M |
November 03, 2021 | 142.94M |
September 30, 2021 | 142.94M |
July 30, 2021 | 142.83M |
June 30, 2021 | 142.83M |
May 04, 2021 | 141.47M |
Date | Value |
---|---|
April 20, 2021 | 141.47M |
March 31, 2021 | 141.48M |
February 24, 2021 | 140.59M |
December 31, 2020 | 140.58M |
December 17, 2020 | 138.76M |
November 04, 2020 | 131.49M |
September 30, 2020 | 128.92M |
August 05, 2020 | 126.65M |
June 30, 2020 | 126.65M |
May 19, 2020 | 124.48M |
May 13, 2020 | 114.70M |
May 07, 2020 | 113.75M |
April 20, 2020 | 110.17M |
March 31, 2020 | 110.17M |
February 21, 2020 | 109.40M |
December 31, 2019 | 109.38M |
November 05, 2019 | 99.56M |
September 30, 2019 | 96.63M |
August 23, 2019 | 94.84M |
August 02, 2019 | 94.76M |
June 30, 2019 | 93.36M |
May 03, 2019 | 90.84M |
April 18, 2019 | 89.40M |
March 31, 2019 | 88.54M |
March 05, 2019 | 88.59M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
90.84M
Minimum
May 03 2019
154.42M
Maximum
Feb 23 2024
132.85M
Average
142.82M
Median
Feb 23 2022
Shares Outstanding Benchmarks
Amicus Therapeutics Inc | 295.38M |
Geron Corp | 546.06M |
Editas Medicine Inc | 81.81M |
G1 Therapeutics Inc | 52.20M |
Mersana Therapeutics Inc | 121.30M |